Vigo
Campus
![Foto de Vigo](/img/noimage.png)
![Foto de Hospital Universitario 12 de Octubre](/img/noimage_org.png)
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (22)
2023
-
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension
American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158
-
Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature
Genes, Vol. 14, Núm. 10
-
Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension
Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 460-467
2022
-
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500
-
First Genotype-Phenotype Study in TBX4 Syndrome Gain-of-Function Mutations Causative for Lung Disease
American Journal of Respiratory and Critical Care Medicine, Vol. 206, Núm. 12, pp. 1522-1533
2021
-
Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
Cells, Vol. 10, Núm. 6
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy
Antioxidants, Vol. 10, Núm. 7
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2020
-
Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients
Scientific Reports, Vol. 10, Núm. 1
-
Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4
PLoS ONE, Vol. 15, Núm. 4
-
Next-generation sequencing for tumor mutation quantification using liquid biopsies
Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 2, pp. 306-313
-
Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy
Future Medicinal Chemistry, Vol. 12, Núm. 13, pp. 1201-1204
2019
-
Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 44, pp. 22300-22306
-
Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics
Cancers, Vol. 11, Núm. 11
-
Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 6, pp. 1025-1029
2018
-
Melatonin: A hypothesis for Kawasaki disease treatment
Medical Hypotheses, Vol. 119, pp. 6-10
2016
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
2007
-
Prolactin-releasing peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo
Endocrine, Vol. 31, Núm. 2, pp. 119-124
2004
-
Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension
Journal of Hypertension, Vol. 22, Núm. 4, pp. 837-846